Merck & Co. Stock Performance Outpaces Market Amid Acquisition
Shares of Merck & Co., Inc. (MRK) have outperformed both the S&P 500 Index ($SPX) and healthcare sector ETF XLV over the past year, with a 34.7% gain in the last 52 weeks compared to 29% for $SPX. The stock also rose following its acquisition of Terns Pharmaceuticals (TERN), valued at approximately $6.7 billion.